A critical review of chronic kidney disease as a risk factor for coronary artery disease

被引:9
作者
Coyle, Mark [1 ]
Flaherty, Gerard
Jennings, Catriona
机构
[1] Natl Inst Prevent & Cardiovasc Hlth, Galway, Ireland
来源
IJC HEART & VASCULATURE | 2021年 / 35卷
关键词
Coronary artery disease and chronic kidney disease; Cardiorenal syndrome; Cardiovascular prevention; Coronary artery disease progression; ACUTE MYOCARDIAL-INFARCTION; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; RENAL-FUNCTION; BLOOD-PRESSURE; LONG-TERM; VASCULAR CALCIFICATION; ANTIPLATELET THERAPY; CARDIORENAL SYNDROME; HEART-ASSOCIATION;
D O I
10.1016/j.ijcha.2021.100822
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic kidney disease (CKD) is a significant risk factor for cardiovascular disease (CVD). In addition to common CVD risk factors, the presence of CKD is independently associated with an elevated cardiovascular (CV) risk. We examined the association between CKD and CVD, focusing on coronary artery disease (CAD) in both primary and secondary CVD. A total of 94 articles were included for this review using search strategies on Pubmed and Google scholar. The main findings of our review included that besides sharing common risk factors, CKD induces several physiological microscopic changes leading to increased CV risk. These microscopic changes manifest macroscopically with evidence of the development of primary CAD in CKD patients, in addition to accelerating CAD in those with pre-established CV pathology, with CKD consequently being a risk factor for both primary and secondary CAD progression. Current CV guideline recommendations do not discriminate between those patients with and without CKD. Future research is needed in this area, examining if there may be a role for tighter modifiable risk factor targets in this high-risk population. (C) 2021 The Author(s). Published by Elsevier B.V.
引用
收藏
页数:7
相关论文
共 95 条
  • [1] Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes
    Al Suwaidi, J
    Reddan, DN
    Williams, K
    Pieper, KS
    Harrington, RA
    Califf, RM
    Granger, CB
    Ohman, EM
    Holmes, DR
    [J]. CIRCULATION, 2002, 106 (08) : 974 - 980
  • [2] Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365
  • [3] Arnett DK, 2019, CIRCULATION, V140, pE563, DOI [10.1161/CIR.0000000000000678, 10.1161/CIR.0000000000000677, 10.1016/j.jacc.2019.03.009, 10.1016/j.jacc.2019.03.010]
  • [4] Attar Armin, 2019, Iran J Kidney Dis, V13, P328
  • [5] Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting
    Azar, RR
    Prpic, R
    Ho, KKL
    Kiernan, FJ
    Shubrooks, SJ
    Baim, DS
    Popma, JJ
    Kuntz, RE
    Cohen, DJ
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (05) : 485 - 489
  • [6] Temporal Trends in Utilization of Cardiac Therapies and Outcomes for Myocardial Infarction by Degree of Chronic Kidney Disease: A Report From the NCDR Chest Pain MI Registry
    Bagai, Akshay
    Lu, Di
    Lucas, Joseph
    Goyal, Abhinav
    Herzog, Charles A.
    Wang, Tracy Y.
    Goodman, Shaun G.
    Roe, Matthew T.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (24):
  • [7] Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
    Baigent, C.
    Landray, M.
    Reith, C.
    Dasgupta, T.
    Emberson, J.
    Herrington, W.
    Lewis, D.
    Mafham, M.
    Collins, R.
    Collins, R.
    Baigent, C.
    Landray, M.
    Bray, C.
    Chen, Y.
    Baxter, A.
    Young, A.
    Hill, M.
    Knott, C.
    Cass, A.
    Feldt-Rasmussen, B.
    Fellstroem, B.
    Grobbee, R.
    Groenhagen-Riska, C.
    Haas, M.
    Holdaas, H.
    Hooi, L. S.
    Jiang, L.
    Kasiske, B.
    Krairittichai, U.
    Levin, A.
    Massy, Z.
    Tesar, V.
    Walker, R.
    Wanner, C.
    Wheeler, D.
    Wiecek, A.
    Dasgupta, T.
    Lewis, D.
    Mafham, M.
    Majoni, W.
    Reith, C.
    Simpson, D.
    Strony, J.
    Musliner, T.
    Agodoa, L.
    Armitage, J.
    Chen, Z.
    Craig, J.
    de Zeeuw, D.
    Gaziano, M.
    [J]. AMERICAN HEART JOURNAL, 2010, 160 (05) : 785 - U28
  • [8] Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
    Baigent, C.
    Blackwell, L.
    Emberson, J.
    Holland, L. E.
    Reith, C.
    Bhala, N.
    Peto, R.
    Barnes, E. H.
    Keech, A.
    Simes, J.
    Collins, R.
    [J]. LANCET, 2010, 376 (9753) : 1670 - 1681
  • [9] Management of Coronary Disease in Patients with Advanced Kidney Disease
    Bangalore, S.
    Maron, D. J.
    OBrien, S. M.
    Fleg, J. L.
    Kretov, E., I
    Briguori, C.
    Kaul, U.
    Reynolds, H. R.
    Mazurek, T.
    Sidhu, M. S.
    Berger, J. S.
    Mathew, R. O.
    Bockeria, O.
    Broderick, S.
    Pracon, R.
    Herzog, C. A.
    Huang, Z.
    Stone, G. W.
    Boden, W. E.
    Newman, J. D.
    Ali, Z. A.
    Mark, D. B.
    Spertus, J. A.
    Alexander, K. P.
    Chaitman, B. R.
    Chertow, G. M.
    Hochman, J. S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (17) : 1608 - 1618
  • [10] Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction
    Beattie, JN
    Soman, SS
    Sandberg, KR
    Yee, J
    Borzak, S
    Garg, M
    McCullough, PA
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (06) : 1191 - 1200